Astellas Provides Update on Zolbetuximab Biologics License Application in U.S. ...Middle East

PR Newswire - News
Astellas Provides Update on Zolbetuximab Biologics License Application in U.S.
TOKYO, Jan. 8, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) issued a complete response letter on January 4, 2024, regarding the Biologics License Application (BLA) for...

Hence then, the article about astellas provides update on zolbetuximab biologics license application in u s was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Astellas Provides Update on Zolbetuximab Biologics License Application in U.S. )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News